HUE044552T2 - Triazinalapú radiogyógyszerek és radiológiai képalkotó ágensek - Google Patents
Triazinalapú radiogyógyszerek és radiológiai képalkotó ágensekInfo
- Publication number
- HUE044552T2 HUE044552T2 HUE17187271A HUE044552T2 HU E044552 T2 HUE044552 T2 HU E044552T2 HU E17187271 A HUE17187271 A HU E17187271A HU E044552 T2 HUE044552 T2 HU E044552T2
- Authority
- HU
- Hungary
- Prior art keywords
- triazine based
- based radiopharmaceuticals
- radioimaging agents
- radioimaging
- agents
- Prior art date
Links
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000012217 radiopharmaceutical Substances 0.000 title 1
- 229940121896 radiopharmaceutical Drugs 0.000 title 1
- 230000002799 radiopharmaceutical effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/481—Diagnostic techniques involving the use of contrast agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Radiology & Medical Imaging (AREA)
- Biophysics (AREA)
- High Energy & Nuclear Physics (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dentistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361752350P | 2013-01-14 | 2013-01-14 | |
| US201361785788P | 2013-03-14 | 2013-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE044552T2 true HUE044552T2 (hu) | 2019-11-28 |
Family
ID=51167394
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE17187271 HUE044552T2 (hu) | 2013-01-14 | 2014-01-10 | Triazinalapú radiogyógyszerek és radiológiai képalkotó ágensek |
| HUE14738117A HUE035739T2 (hu) | 2013-01-14 | 2014-01-10 | Triazin alapú radiogyógyszerek és radiológiai képalkotó ágensek |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE14738117A HUE035739T2 (hu) | 2013-01-14 | 2014-01-10 | Triazin alapú radiogyógyszerek és radiológiai képalkotó ágensek |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US9447121B2 (hu) |
| EP (4) | EP3939972A1 (hu) |
| JP (2) | JP6468602B2 (hu) |
| KR (1) | KR102187940B1 (hu) |
| CN (1) | CN105025933B (hu) |
| AU (1) | AU2014205304B2 (hu) |
| BR (1) | BR112015016585B1 (hu) |
| CA (1) | CA2897437C (hu) |
| ES (2) | ES2738474T3 (hu) |
| HK (1) | HK1212908A1 (hu) |
| HU (2) | HUE044552T2 (hu) |
| MX (1) | MX2015008993A (hu) |
| PL (2) | PL3300746T3 (hu) |
| SG (1) | SG11201505477TA (hu) |
| WO (1) | WO2014110372A1 (hu) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201505477TA (en) * | 2013-01-14 | 2015-08-28 | Molecular Insight Pharm Inc | Triazine based radiopharmaceuticals and radioimaging agents |
| EP3415489A1 (en) | 2013-10-18 | 2018-12-19 | Deutsches Krebsforschungszentrum | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| AU2015256002B2 (en) | 2014-05-06 | 2020-01-02 | Northwestern University | Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy |
| US9956305B2 (en) | 2014-09-08 | 2018-05-01 | Molecular Insight Pharmaceuticals, Inc. | Organ protection in PSMA-targeted radionuclide therapy of prostate cancer |
| EP3101012A1 (en) | 2015-06-04 | 2016-12-07 | Bayer Pharma Aktiengesellschaft | New gadolinium chelate compounds for use in magnetic resonance imaging |
| US10688200B2 (en) * | 2015-12-31 | 2020-06-23 | Five Eleven Pharma Inc. | Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy |
| RU2749399C2 (ru) * | 2016-03-22 | 2021-06-09 | Дзе Джонс Хопкинс Юниверсити | Простатический специфический мембранный антиген-таргетные высокоаффинные средства для эндорадиотерапии рака предстательной железы |
| US10340046B2 (en) * | 2016-10-27 | 2019-07-02 | Progenics Pharmaceuticals, Inc. | Network for medical image analysis, decision support system, and related graphical user interface (GUI) applications |
| CN110035996B (zh) | 2016-11-28 | 2022-08-09 | 拜耳医药股份公司 | 用于磁共振成像的新型高弛豫性钆螯合物 |
| WO2018222778A1 (en) * | 2017-05-30 | 2018-12-06 | The Johns Hopkins University | Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer |
| KR102015355B1 (ko) | 2017-06-19 | 2019-10-23 | (주)퓨쳐켐 | 전립선암 진단을 위한 18f-표지된 화합물 및 그의 용도 |
| WO2018236115A1 (ko) * | 2017-06-19 | 2018-12-27 | (주)퓨쳐켐 | 전립선암 진단을 위한 18f-표지된 화합물 및 그의 용도 |
| SI3778592T1 (sl) | 2018-03-30 | 2023-08-31 | Futurechem Co., Ltd. | PSMA-ciljan radiofarmacevtik za diagnosticiranje in zdravljenje raka prostate |
| AU2019382881A1 (en) | 2018-11-23 | 2021-05-20 | Bayer Aktiengesellschaft | Formulation of contrast media and process of preparation thereof |
| AU2022396942A1 (en) * | 2021-11-24 | 2024-05-23 | Clarity Pharmaceuticals Ltd | Compounds and compositions thereof for the treatment of cancer |
Family Cites Families (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2800457A (en) | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
| US2730456A (en) | 1953-06-30 | 1956-01-10 | Ncr Co | Manifold record material |
| US2730457A (en) | 1953-06-30 | 1956-01-10 | Ncr Co | Pressure responsive record materials |
| US3527789A (en) | 1967-10-06 | 1970-09-08 | Shell Oil Co | Production of poly(lower)alkyl alkenepolycarboxylates |
| US3625214A (en) | 1970-05-18 | 1971-12-07 | Alza Corp | Drug-delivery device |
| JPS5220203B2 (hu) | 1973-03-05 | 1977-06-02 | ||
| US4272398A (en) | 1978-08-17 | 1981-06-09 | The United States Of America As Represented By The Secretary Of Agriculture | Microencapsulation process |
| US4906474A (en) | 1983-03-22 | 1990-03-06 | Massachusetts Institute Of Technology | Bioerodible polyanhydrides for controlled drug delivery |
| JPS6131056A (ja) | 1984-07-25 | 1986-02-13 | K Baiorojikaru Sci Lab:Kk | ホイッピングクリームの製造方法 |
| US4885363A (en) | 1987-04-24 | 1989-12-05 | E. R. Squibb & Sons, Inc. | 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
| EP0318512B1 (en) | 1986-08-18 | 1998-06-17 | Emisphere Technologies, Inc. | Delivery systems for pharmacological agents |
| JP2608550B2 (ja) | 1986-10-17 | 1997-05-07 | 株式会社 片山化学工業研究所 | 軟水ボイラの防食処理方法 |
| US4888136A (en) | 1988-05-02 | 1989-12-19 | Witco Corporation | New flame retardant compositions of matter and cellulosic products containing same |
| TW353663B (en) | 1991-04-06 | 1999-03-01 | Hoechst Ag | Process for the preparation of phosphorus-containing L-amino acids, their derivatives and intermediates for this process |
| JP3051497B2 (ja) | 1991-05-17 | 2000-06-12 | 株式会社第一ラジオアイソトープ研究所 | スルファニルアミド誘導体のテクネチウム錯体をもちいる放射性診断剤 |
| US6359120B1 (en) | 1991-10-29 | 2002-03-19 | Bracco International B.V. | Rhenium and technetium complexes containing a hypoxia-localizing moiety |
| IL103353A (en) | 1991-10-29 | 1999-01-26 | Bracco Int Bv | His metal bracelet ligand is a diagnostic product and processes for its preparation |
| IT1270260B (it) | 1994-06-21 | 1997-04-29 | Zambon Spa | Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi |
| US6011021A (en) | 1996-06-17 | 2000-01-04 | Guilford Pharmaceuticals Inc. | Methods of cancer treatment using naaladase inhibitors |
| JP2856098B2 (ja) | 1995-04-11 | 1999-02-10 | 日本製紙株式会社 | 感熱記録シート |
| US5514505A (en) * | 1995-05-15 | 1996-05-07 | Xerox Corporation | Method for obtaining improved image contrast in migration imaging members |
| US5795877A (en) | 1996-12-31 | 1998-08-18 | Guilford Pharmaceuticals Inc. | Inhibitors of NAALADase enzyme activity |
| US6025344A (en) | 1996-06-17 | 2000-02-15 | Guilford Pharmaceuticals Inc. | Certain dioic acid derivatives useful as NAALADase inhibitors |
| US5824662A (en) | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
| US6046180A (en) | 1996-06-17 | 2000-04-04 | Guilford Pharmaceuticals Inc. | NAALADase inhibitors |
| US6071965A (en) | 1996-06-17 | 2000-06-06 | Guilford Pharmaceuticals Inc. | Phosphinic alkanoic acid derivatives |
| US5672592A (en) | 1996-06-17 | 1997-09-30 | Guilford Pharmaceuticals Inc. | Certain phosphonomethyl-pentanedioic acid derivatives thereof |
| US5902817A (en) | 1997-04-09 | 1999-05-11 | Guilford Pharmaceuticals Inc. | Certain sulfoxide and sulfone derivatives |
| TR199901173T2 (xx) | 1996-09-27 | 1999-07-21 | Guilford Pharmaceuticals, Inc. | Canl�larda glutamat anormalli�inin tedavisi ve n�ronal aktivitenin d�zenlenmesi i�in y�ntemler ve NAALADase bile�imleri. |
| US5962521A (en) | 1997-04-04 | 1999-10-05 | Guilford Pharmaceuticals Inc. | Hydroxamic acid derivatives |
| ZA983930B (en) | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
| NZ507032A (en) | 1998-03-19 | 2003-06-30 | Pharmacia & Upjohn | 1,3,4-thiadiazoles useful for the treatment of herpes and cytomegalovirus infections |
| JP5095050B2 (ja) | 1999-04-28 | 2012-12-12 | ジョージタウン ユニバーシティー | 代謝調節型グルタミン酸受容体のリガンド、及び、ＮＡＡＬＡＤａｓｅの阻害剤 |
| US6528499B1 (en) | 2000-04-27 | 2003-03-04 | Georgetown University | Ligands for metabotropic glutamate receptors and inhibitors of NAALADase |
| US6228888B1 (en) | 1999-07-01 | 2001-05-08 | Guilford Pharmaceuticals Inc. | Methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitors |
| CN1630517A (zh) | 2001-05-24 | 2005-06-22 | 吴羽化学工业株式会社 | 包含含氮化合物的具有cxcr4拮抗作用的药物 |
| DE10135355C1 (de) | 2001-07-20 | 2003-04-17 | Schering Ag | Konjugate makrocyclischer Metallkomplexe mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR- und Radiodiagnostik sowie die Radiotherapie |
| US20030100594A1 (en) | 2001-08-10 | 2003-05-29 | Pharmacia Corporation | Carbonic anhydrase inhibitor |
| JP4303595B2 (ja) | 2001-12-21 | 2009-07-29 | 透 小池 | アニオン性置換基を有する物質を捕捉可能な亜鉛錯体 |
| DK1472541T3 (da) | 2002-01-10 | 2010-01-25 | Univ Johns Hopkins | Afbildningsmidler og metoder til at afbilde NAALADase og PSMA |
| JP4846199B2 (ja) | 2002-03-11 | 2011-12-28 | モレキュラ インサイト ファーマシューティカルズ インコーポレイテッド | テクネチウム−ジビリジン複合体、およびその使用法 |
| JP3714948B2 (ja) | 2002-09-11 | 2005-11-09 | 呉羽化学工業株式会社 | アミン化合物及びその用途 |
| US7833734B2 (en) | 2002-11-26 | 2010-11-16 | Institute Of Virology Of The Slovak Academy Of Sciences | CA IX-specific inhibitors |
| US7550424B2 (en) | 2002-11-26 | 2009-06-23 | Institute Of Virology Slovak Academy Of Sciences | CA IX-specific inhibitors |
| US7291631B2 (en) | 2003-04-11 | 2007-11-06 | Genzyme Corporation | CXCR4 chemokine receptor binding compounds |
| US7682601B2 (en) | 2003-04-15 | 2010-03-23 | Mallinckrodt Inc. | Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes |
| EP1692099A1 (en) | 2003-12-12 | 2006-08-23 | Oy Juvantia Pharma Ltd | Somatostatine receptor subtype 1 (sstr1) active compounds and their use in therapy |
| AU2005215510A1 (en) | 2004-02-12 | 2005-09-01 | Molecular Insight Pharmaceuticals, Inc. | Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| GB0421308D0 (en) | 2004-09-24 | 2004-10-27 | Amersham Plc | Enzyme inhibitor imaging agents |
| WO2008059489A2 (en) | 2006-11-13 | 2008-05-22 | Spectrum Dynamics Llc | Radioimaging applications of and novel formulations of teboroxime |
| WO2006080993A1 (en) | 2004-12-08 | 2006-08-03 | Purdue Research Foundation | Novel cationic metal complex radiopharmaceuticals |
| US7741510B2 (en) | 2005-01-13 | 2010-06-22 | E. I. Du Pont De Nemours And Company | Rheology control agents |
| US20060155021A1 (en) | 2005-01-13 | 2006-07-13 | Lenges Christian P | Coating compositions containing rheology control agents |
| WO2006093991A1 (en) | 2005-03-02 | 2006-09-08 | The Cleveland Clinic Foundation | Compounds which bind psma and uses thereof |
| DK1875239T3 (da) | 2005-04-27 | 2012-01-23 | Siemens Medical Solutions | Fremgangsmåde til fremstilling af billeddannelsessonder under anvendelse af klik-kemi |
| US8871720B2 (en) | 2005-07-07 | 2014-10-28 | Seattle Genetics, Inc. | Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus |
| FR2890657B1 (fr) | 2005-09-15 | 2007-11-09 | Commissariat Energie Atomique | Procede d'obtention de complexes de lanthanides hautement luminescents. |
| WO2007042504A2 (fr) | 2005-10-07 | 2007-04-19 | Guerbet | Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium |
| US8168783B2 (en) | 2005-11-18 | 2012-05-01 | Ono Pharmaceutical Co., Ltd. | Chemokine receptor antagonists and use thereof |
| BRPI0621307A2 (pt) | 2006-02-06 | 2011-12-06 | Ciba Holding Inc | uso de compostos de complexo metálico como catalisadores de oxidação |
| WO2007132846A1 (ja) | 2006-05-16 | 2007-11-22 | Ono Pharmaceutical Co., Ltd. | 保護されていてもよい酸性基を含有する化合物およびその用途 |
| KR20090018657A (ko) | 2006-06-20 | 2009-02-20 | 이시하라 산교 가부시끼가이샤 | 신규 피리딜-메탄아민 유도체 또는 그의 염을 함유하는 유해 생물 방제제 |
| WO2008016006A1 (en) | 2006-07-31 | 2008-02-07 | Ono Pharmaceutical Co., Ltd. | Compound having cyclic group bound thereto through spiro binding and use thereof |
| EP2061518A4 (en) | 2006-08-29 | 2011-05-11 | Molecular Insight Pharm Inc | RADIOIMAGING FRAGMENTS COUPLED WITH PEPTIDASIA BINDING FRAGMENTS FOR IMAGING TISSUES AND BODIES EXPRESSING PEPTIDASES |
| SI2097111T1 (sl) * | 2006-11-08 | 2016-02-29 | Molecular Insight Pharmaceuticals, Inc. | Heterodimeri glutaminske kisline |
| JP2010523599A (ja) | 2007-04-05 | 2010-07-15 | シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド | クリックケミストリーを使用した炭酸脱水酵素−ｉｘのための分子イメージングプローブの開発 |
| US20090180951A1 (en) | 2007-12-12 | 2009-07-16 | Molecular Insight Pharmaceuticals, Inc. | Inhibitors of integrin vla-4 |
| CN102083427B (zh) | 2008-01-09 | 2014-12-10 | 分子洞察制药公司 | 碳酸酐酶ix的抑制剂 |
| UY31885A (es) * | 2008-06-11 | 2010-01-29 | Astrazeneca Ab | Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones. |
| BRPI0919818A2 (pt) | 2008-09-25 | 2019-09-24 | Molecular Insight Pharm Inc | inibidores de seprase seletivos |
| EP2706057B1 (en) | 2008-12-05 | 2016-04-20 | Molecular Insight Pharmaceuticals, Inc. | Bis(imidazolyl)compounds and radionuclide complexes |
| WO2010065906A2 (en) | 2008-12-05 | 2010-06-10 | Molecular Insight Pharmaceuticals, Inc. | Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer |
| TW201034691A (en) | 2008-12-05 | 2010-10-01 | Molecular Insight Pharm Inc | Technetium-and rhenium-bis(heteroaryl) complexes and methods of use thereof |
| ES2712732T3 (es) | 2009-02-17 | 2019-05-14 | Cornell Res Foundation Inc | Métodos y kits para el diagnóstico de cáncer y la predicción de valor terapéutico |
| EP3964502A1 (en) * | 2009-03-19 | 2022-03-09 | The Johns Hopkins University | Psma-targeting compounds and uses thereof |
| GB201002508D0 (en) * | 2010-02-12 | 2010-03-31 | Algeta As | Product |
| US9649394B2 (en) * | 2010-11-22 | 2017-05-16 | The General Hospital Corporation | Compositions and methods for in vivo imaging |
| JP6275484B2 (ja) | 2010-12-06 | 2018-02-07 | モレキュラ インサイト ファーマシューティカルズ インコーポレイテッド | Ｐｓｍａ標的化デンドリマー |
| JP5843338B2 (ja) | 2011-08-05 | 2016-01-13 | モレキュラ インサイト ファーマシューティカルズ インコーポレイテッド | 放射標識された前立腺特異的膜抗原阻害剤 |
| WO2013166110A1 (en) | 2012-05-02 | 2013-11-07 | Yale University | Tlr-agonist-conjugated antibody recruiting molecules (tlr_arms) |
| SG11201505477TA (en) * | 2013-01-14 | 2015-08-28 | Molecular Insight Pharm Inc | Triazine based radiopharmaceuticals and radioimaging agents |
-
2014
- 2014-01-10 SG SG11201505477TA patent/SG11201505477TA/en unknown
- 2014-01-10 KR KR1020157021666A patent/KR102187940B1/ko active IP Right Grant
- 2014-01-10 WO PCT/US2014/011047 patent/WO2014110372A1/en active Application Filing
- 2014-01-10 HU HUE17187271 patent/HUE044552T2/hu unknown
- 2014-01-10 CA CA2897437A patent/CA2897437C/en active Active
- 2014-01-10 MX MX2015008993A patent/MX2015008993A/es unknown
- 2014-01-10 EP EP21190931.2A patent/EP3939972A1/en not_active Withdrawn
- 2014-01-10 EP EP14738117.2A patent/EP2943227B8/en active Active
- 2014-01-10 CN CN201480011222.1A patent/CN105025933B/zh active Active
- 2014-01-10 US US14/152,864 patent/US9447121B2/en active Active
- 2014-01-10 PL PL17187271T patent/PL3300746T3/pl unknown
- 2014-01-10 BR BR112015016585-0A patent/BR112015016585B1/pt active IP Right Grant
- 2014-01-10 EP EP17187271.6A patent/EP3300746B1/en active Active
- 2014-01-10 AU AU2014205304A patent/AU2014205304B2/en active Active
- 2014-01-10 JP JP2015552805A patent/JP6468602B2/ja active Active
- 2014-01-10 ES ES17187271T patent/ES2738474T3/es active Active
- 2014-01-10 PL PL14738117T patent/PL2943227T3/pl unknown
- 2014-01-10 ES ES14738117.2T patent/ES2648096T3/es active Active
- 2014-01-10 HU HUE14738117A patent/HUE035739T2/hu unknown
- 2014-01-10 EP EP19174044.8A patent/EP3545978B1/en active Active
-
2016
- 2016-01-28 HK HK16100926.1A patent/HK1212908A1/zh unknown
- 2016-08-10 US US15/233,096 patent/US10201624B2/en active Active
-
2017
- 2017-04-20 US US15/492,933 patent/US10086096B2/en active Active
-
2018
- 2018-12-21 US US16/231,153 patent/US10898598B2/en active Active
-
2019
- 2019-01-10 JP JP2019002515A patent/JP6707677B2/ja active Active
-
2020
- 2020-12-21 US US17/129,825 patent/US11712485B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1212908A1 (zh) | 三嗪類放射性藥物和放射性顯影劑 | |
| IL274355B (en) | Aza-pyridone compounds and their uses | |
| HK1225382A1 (zh) | 噠嗪酮化合物及其用途 | |
| HUE044890T2 (hu) | Tetrazolinon vegyület és annak felhasználása | |
| GB201323008D0 (en) | Compounds and uses thereof | |
| IL240248A0 (en) | Met-binding substances and their uses | |
| GB2513227B (en) | Backpack | |
| IL245597A0 (en) | Anti-neuroinflammatory and protective compounds in Achillea fragrantissima - implications for inflammatory and neurodegenerative diseases | |
| GB201322456D0 (en) | Radiotracer compositions and methods | |
| GB201307233D0 (en) | Compounds and uses thereof | |
| GB201311107D0 (en) | Bioorthogonal methods and compounds | |
| GB201321056D0 (en) | Debug circuitry | |
| GB201309180D0 (en) | Compounds and Their Uses | |
| GB201314610D0 (en) | Compounds and their uses | |
| GB201305297D0 (en) | Novel agents and uses thereof | |
| GB201306248D0 (en) | Compounds and their uses | |
| EP3037100A4 (en) | MEANS TO PREVENT MUSCLE ATROPHY | |
| HK1213898A1 (zh) | 新型美白劑 | |
| AU353456S (en) | Hammock | |
| GB201309248D0 (en) | Compounds and combinations | |
| GB201313405D0 (en) | Hammock | |
| GB201323005D0 (en) | Compounds and uses thereof | |
| GB201320161D0 (en) | Compounds and their uses | |
| GB201307201D0 (en) | New compounds and uses | |
| GB201307202D0 (en) | New compounds and uses |